Clinical Case Reports (Jun 2021)

Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus

  • Arthur E. Frankel,
  • Wai C. Yip,
  • Eknath Naik,
  • Hans C. Hasselbalch

DOI
https://doi.org/10.1002/ccr3.4218
Journal volume & issue
Vol. 9, no. 6
pp. n/a – n/a

Abstract

Read online

Abstract A 61‐year‐old male on everolimus had chronic SARS‐CoV‐2 infection. Addition of pegylated interferon cleared viral RNA and supports combination therapy with everolimus plus interferon for COVID‐19.

Keywords